# Meta-Reflection

## Executive Summary
Post ID: 42048 - Will ECDC weekly SARS-CoV-2 test positivity show 4 consecutive week-over-week increases for EU/EEA before May 1, 2026?

Final forecast: ~15% probability (Yes)
Confidence: Moderate-high

## Research Audit
- Primary data source (ECDC CSV) was directly fetched and analyzed - this was the most valuable step
- Historical analysis of W06-W17 windows across 2022-2025 was definitive
- Sliding window analysis with matching conditions (low positivity, declining, W05-W08 start) showed 0/4 rate
- Monte Carlo simulations provided range estimates (8-18%)
- COVID variant search yielded limited 2026-specific information
- Most informative: the actual data series showing patterns at low positivity levels

## Reasoning Quality Check

Strongest evidence FOR my forecast (low probability):
1. 0/4 matching historical windows (low + declining + same seasonal timing) produced 4+ consecutive increases
2. At very low positivity (1-3%), the EU/EEA aggregate shows mean-reverting noise that breaks streaks
3. Even during 2025 spring wave onset, max was only 2 consecutive increases
4. Spring waves in 2024/2025 started after W17

Strongest argument AGAINST my forecast:
- 2023 showed it IS possible (W06-W09 had 4 consecutive increases)
- A new immune-evasive variant could produce an atypically early spring surge
- The IID model gives ~8% and Markov gives ~18%, suggesting my estimate shouldn't be too low
- Small sample size (only 4 years) makes the 0/4 rate unstable

Calibration check:
- This is a predictive question about a specific statistical pattern
- "Nothing Ever Happens" applies somewhat - sustained increases require active epidemiological change
- But COVID DOES regularly produce waves, so the question is timing
- 15% accounts for: ~10% base from statistical models + ~5% for unknown variant/early wave scenarios
- This is somewhat higher than the 0/4 conditional base rate but lower than the 1/4 unconditional rate

## Subagent Decision
Did not use subagents - the question was data-driven and the primary CSV was directly analyzable. Multiple Monte Carlo simulations and historical analyses were sufficient. Subagents would have added overhead without benefit.

## Tool Effectiveness
- execute_code: Excellent - essential for CSV parsing and Monte Carlo simulations
- search_exa: Limited results for 2026-specific COVID news
- get_metaculus_questions: Useful for full question context
- No tool failures encountered

## Process Feedback
- Direct data analysis was the right approach for this question
- The sliding window analysis with matching conditions was the most informative technique
- Could have also checked individual country-level data for leading indicators

## Calibration Tracking
- 85% CI: [0.08, 0.25]
- I'm ~80% confident in the 15% estimate
- Update triggers: emergence of a new dominant variant by W08, or positivity reversal in W06 data
---

## Programmatic Metrics

*Auto-generated - do not edit manually*

- **Post ID**: 42048
- **Question ID**: 41796
- **Session Duration**: 330.6s (5.5 min)
- **Cost**: $4.4885
- **Tokens**: 18,819 total (46 in, 18,773 out)
  - Cache: 1,126,843 read, 74,111 created
- **Log File**: `logs/42048_20260211_193525/20260211-193526.log`

### Tool Calls

- **Total**: 21 calls
- **Errors**: 0 (0.0%)

| Tool | Calls | Errors | Avg Time |
|------|-------|--------|----------|
| execute_code | 13 | 0 | 176ms |
| get_metaculus_questions | 1 | 0 | 918ms |
| get_prediction_history | 1 | 0 | 0ms |
| notes | 2 | 0 | 1ms |
| search_exa | 4 | 0 | 6491ms |

### Sources Consulted

- COVID SARS-CoV-2 new variant Europe 2026 winter spring wave
- ECDC ERVISS respiratory virus surveillance SARS-CoV-2 positivity February 2026
- COVID variant XEC KP LB1 new dominant variant early 2026
- COVID SARS-CoV-2 new variant January February 2026 Europe surge